CBD Life Sciences Inc. (CBDL) Announces Company Will Exhibit at the NECANN Cannabis Conference in Atlantic City, NJ
CBD Life Sciences (OTC:CBDL) announced its participation in the NECANN Cannabis Conference, scheduled for September 5-6, 2025, in Atlantic City, NJ. The company will showcase its flagship brand The CBD Vault at Booth 837.
NECANN New Jersey, ranked as the 3rd largest B2B cannabis convention in the US, is expected to attract over 5,000 attendees and feature more than 200 exhibitors. The event provides CBDL with opportunities to strengthen distribution networks, expand market reach, and connect with potential investors in the Mid-Atlantic region.
The global CBD market is projected to reach $69 billion by 2029, with a CAGR exceeding 31%. This exhibition aligns with CBDL's strategy to enhance brand visibility and capture market share in one of the nation's fastest-growing regions.
CBD Life Sciences (OTC:CBDL) ha confermato la sua partecipazione al NECANN Cannabis Conference, in programma il 5-6 settembre 2025 ad Atlantic City, NJ. L'azienda presenterà il suo marchio principale, The CBD Vault presso lo Stand 837.
NECANN New Jersey, riconosciuto come il 3° più grande convegno B2B sulla cannabis negli Stati Uniti, dovrebbe attirare oltre 5.000 partecipanti e ospitare più di 200 espositori. L'evento offrirà a CBDL l'occasione per rafforzare le reti distributive, ampliare la presenza sul mercato e incontrare potenziali investitori nella regione Mid-Atlantic.
Il mercato globale del CBD è previsto raggiungere i 69 miliardi di dollari entro il 2029, con un CAGR superiore al 31%. Questa esposizione è in linea con la strategia di CBDL di aumentare la visibilità del marchio e conquistare quote in una delle regioni a più rapida crescita del paese.
CBD Life Sciences (OTC:CBDL) anunció su participación en la NECANN Cannabis Conference, programada para el 5 y 6 de septiembre de 2025 en Atlantic City, NJ. La compañía exhibirá su marca principal, The CBD Vault en el Stand 837.
NECANN New Jersey, calificado como la 3.ª convención B2B de cannabis más grande en EE. UU., se espera que atraiga a más de 5.000 asistentes y cuente con más de 200 expositores. El evento brinda a CBDL oportunidades para fortalecer redes de distribución, ampliar su alcance en el mercado y conectar con posibles inversores en la región Mid-Atlantic.
Se proyecta que el mercado global del CBD alcance los 69.000 millones de dólares para 2029, con una TACC superior al 31%. Esta participación está alineada con la estrategia de CBDL de aumentar la visibilidad de su marca y ganar cuota de mercado en una de las regiones de más rápido crecimiento del país.
CBD Life Sciences (OTC:CBDL)는 2025년 9월 5~6일 뉴저지 애틀랜틱시티에서 열리는 NECANN Cannabis Conference에 참가한다고 발표했습니다. 회사는 대표 브랜드 The CBD Vault를 부스 837에서 선보일 예정입니다.
NECANN 뉴저지는 미국에서 3번째로 큰 B2B 대마(칸나비스) 컨벤션으로 평가되며, 5,000명 이상의 참가자와 200개 이상의 전시업체가 예상됩니다. 이번 행사는 CBDL이 유통망을 강화하고 시장 침투를 넓히며 중대서부(Mid-Atlantic) 지역의 잠재 투자자들과 교류할 기회를 제공합니다.
글로벌 CBD 시장은 2029년까지 690억 달러에 이를 것으로 전망되며, 연평균 성장률(CAGR)은 31% 이상입니다. 이번 전시는 빠르게 성장하는 지역 중 하나에서 브랜드 인지도를 높이고 시장 점유율을 확대하려는 CBDL의 전략과 일치합니다.
CBD Life Sciences (OTC:CBDL) a annoncé sa participation à la NECANN Cannabis Conference, prévue les 5 et 6 septembre 2025 à Atlantic City, NJ. La société présentera sa marque phare, The CBD Vault au Stand 837.
NECANN New Jersey, classé comme la 3e plus grande convention B2B du cannabis aux États‑Unis, devrait attirer plus de 5 000 participants et réunir plus de 200 exposants. L'événement offrira à CBDL des opportunités pour renforcer ses réseaux de distribution, étendre sa présence sur le marché et entrer en contact avec des investisseurs potentiels dans la région Mid‑Atlantic.
Le marché mondial du CBD devrait atteindre 69 milliards de dollars d'ici 2029, avec un TCAC supérieur à 31%. Cette participation s'inscrit dans la stratégie de CBDL visant à accroître la visibilité de la marque et à conquérir des parts de marché dans l'une des régions à la croissance la plus rapide du pays.
CBD Life Sciences (OTC:CBDL) gab bekannt, dass das Unternehmen an der NECANN Cannabis Conference teilnimmt, die am 5. und 6. September 2025 in Atlantic City, NJ, stattfindet. Das Unternehmen wird seine Flaggschiff‑Marke The CBD Vault am Stand 837 präsentieren.
NECANN New Jersey, das als die drittgrößte B2B‑Cannabis‑Konvention in den USA gilt, wird voraussichtlich über 5.000 Besucher anziehen und mehr als 200 Aussteller aufweisen. Die Veranstaltung bietet CBDL die Möglichkeit, Vertriebsnetze zu stärken, die Marktpräsenz auszubauen und potenzielle Investoren in der Mid‑Atlantic‑Region zu treffen.
Der globale CBD‑Markt wird bis 2029 voraussichtlich 69 Milliarden US‑Dollar erreichen, mit einer CAGR von über 31%. Diese Messe passt zur Strategie von CBDL, die Markenbekanntheit zu steigern und Marktanteile in einer der am schnellsten wachsenden Regionen des Landes zu sichern.
- None.
- None.
NECANN New Jersey attracts over 5,000 industry leaders, features more than 200 exhibitors, and is ranked the 3rd largest B2B cannabis convention in the United States - positioning CBDL for unprecedented growth, revenue opportunities, and investor value.
SCOTTSDALE, ARIZONA / ACCESS Newswire / August 27, 2025 / CBD Life Sciences Inc. (OTC:CBDL), a trailblazer in the CBD and wellness industry, proudly announces that the Company will be exhibiting at the NECANN Cannabis Conference in Atlantic City, New Jersey, on September 5-6, 2025 at the New Jersey Convention Center. CBDL will showcase its flagship brand The CBD Vault at Booth 837, with exhibition hours scheduled for Friday (10AM-5PM) and Saturday (10AM-4PM).
Since its inception in 2019, NECANN New Jersey has rapidly ascended to become the largest and most influential gathering in the Mid-Atlantic cannabis sector, now ranked as the 3rd largest B2B cannabis convention nationwide. This year's event is expected to draw over 5,000 attendees, 200+ exhibitors, and more than 75 licensed cultivators, retailers, and brands, alongside investors, distributors, and industry thought leaders.
The 2025 event also introduces the first-ever New Jersey NECANN CUP, creating even greater visibility and opportunities for recognition among the cannabis industry's most innovative brands.
Why NECANN Matters for CBD Life Sciences Inc. and Its Shareholders
Exhibiting at NECANN is not just a branding opportunity, it is a gateway to accelerated growth, expanded partnerships, and revenue potential. For CBDL, this platform represents a multi-faceted opportunity to:
Strengthen Distribution Networks: Connect with hundreds of B2B buyers, wholesalers, and retailers who are actively seeking new product lines to carry.
Expand Market Reach: Enter the Mid-Atlantic market, one of the fastest-growing cannabis and CBD regions in the United States.
Accelerate Revenue Streams: NECANN is widely recognized as a hub for client acquisition, high-value deals, and long-term recurring revenue opportunities.
Attract New Investors & Strategic Partners: Build relationships with institutional and private investors looking to capitalize on the explosive CBD and cannabis industries.
Elevate Brand Visibility: Present The CBD Vault alongside 200+ of the industry's top innovators, ensuring the Company is positioned at the center of industry progress.
"NECANN is where opportunity meets execution," stated Lisa Nelson, President & CEO of CBD Life Sciences Inc. "We are honored to exhibit The CBD Vault at Booth 837, and we see this event as a critical inflection point for our Company. NECANN has proven to be a catalyst for partnerships, revenue growth, and investor confidence-and we are confident that the doors opened in Atlantic City will fuel CBDL's upward trajectory well into 2026 and beyond."
A Market Poised for Explosive Growth
The global CBD market continues to demonstrate exponential growth, with analysts projecting it to surpass
By aligning with NECANN, CBD Life Sciences Inc. is strategically positioning itself to capture market share in one of the nation's fastest-growing regions, while building long-term shareholder value through brand awareness, product adoption, and increased sales volume.
Commitment to Shareholders and Long-Term Value
CBDL's decision to exhibit at NECANN underscores the Company's unwavering commitment to delivering consistent growth, enhanced visibility, and expanded revenue channels for its shareholders. With every milestone-whether entering Walmart Marketplace, announcing new product launches, or securing retail expansion-CBDL continues to reinforce its reputation as a company on the rise.
The NECANN exhibition represents yet another bold step forward in this trajectory, one that is expected to create lasting impact for both current investors and potential future stakeholders.
Event Details:
New Jersey Convention Center - Atlantic City, NJ
September 5-6, 2025
Booth #837 - The CBD Vault
Friday: 10AM-5PM | Saturday: 10AM-4PM
For more information on NECANN New Jersey, please visit https://necann.com.
About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. is an innovative health and wellness company committed to the research, development, and distribution of premium cannabidiol (CBD) products through its core brand, CBD Vault. From topicals and tinctures to wellness beverages and skincare solutions, CBDL is building a portfolio of products designed for maximum efficacy, transparency, and consumer trust.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire
FAQ
When and where is CBD Life Sciences (CBDL) exhibiting at the NECANN Cannabis Conference?
What is the significance of NECANN New Jersey for CBD Life Sciences?
What is the projected growth of the global CBD market according to CBDL's announcement?
Who is the CEO of CBD Life Sciences (CBDL)?
What brand will CBD Life Sciences showcase at NECANN?
